Functional analysis of tumor-infiltrating leukocytes in breast cancer patients

Journal of Surgical Research

Volumn 76, Issue 1, 1998, Pages 95-103

  Wong, Peter Y ^a   Staren, Edgar D ^a   Tereshkova, Natasha ^a   Braun, Donald P ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

Breast cancer; Cytokines; Cytotoxicity assays; IFN ; IL 10; IL 2; IL 4; IL 6; Leukocytic phenotypes; Lymph node leukocytes; Peripheral blood leukocytes; TNF ; Tumor infiltrating leukocytes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AXILLARY LYMPH NODE; BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0031879969     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5301     Document Type: Conference Paper

References (31)

1. Greenfield L. J., Mulholland M. W., Oldham K. T., Zelenoch G. B. Textbook of Surgery Scientific Principle and Practice. 1993;. p. 1235-1285.
2. O'Sullivan C., Lewis C. E. Tumor-associated leucocytes: Friends or foes in breast carcinoma. J. Pathol. 172:1994;229.
3. Bassler R., Dittmann A. M., Dittrich M. Mononuclear stromal reactions in mammary carcinoma, with reference to medullary cardinomas with alymphoid infiltrate. Virchows Arch. (Pathol. Anat.). 393:1981;75.
4. Black M. M., Barclay T. H. C. Prognosis in breast cancer utilizing histilogic characteristics of the primary tumor. Cancer. 36:1975;2048.
5. Hamlin I. M. E. Possible host resistance in carcinoma of the breast: A histological study. Br. J. Cancer. 22:1968;383.
6. Peoples G. E., Blotnick S., Takahashi K., Freeman M. R., Klagsbrun M., Eberlein T. J. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: A potential pathologic role. Proc. Natl. Acad. Sci. USA. 92:1995;6547.
7. Ogmundsdottir H. M., Petursdottir I., Gudmundsdottir I. Interactions between the immune system and breast cancer. Acta Oncol. 34:1995;647.
8. Staren E. D., Economou S. G., Harris J. E., Braun D. P. Lymphokine-activated killer cell induction in tumor-infiltrating leukocytes from colon cancer patients. Cancer. 64:1989;2238.
9. Whitford P., Alam S. M., George W. D., Campbell A. M. Flow cytometric analysis of tumor draining lymph nodes in breast cancer patients. Eur J. Cancer. 28:1992;350.
10. Kreft B., Singer G. G., Diaz-Gallo C., Kelley V. R. Detection of intracellular interleukin-10 by flow cytometry. J. Immunol. Methods. 156:1992;125.
11. Prussin C., Metcalfe D. D. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods. 188:1995;117.
12. Becton Dickinson procedures, Intracellular staining procedures 1996.
13. Becton Dickinson Immunocytometry Systems, FACScan User's Guide 1990.
14. Riley, R. S. Mahin, E. J. Clinical Applications of Flow Cytometry 1990.
15. Morton B. A., Ramey W. G., Paderon H., Miller R. E. Monoclonal antibody defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer. Cancer Res. 46:1986;2121.
16. Topalian S. L., Muul L. M., Solomon D. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods. 102:1987;127.
17. Griffith C. D. M., Ellis I. O., Bell J., Burns K., Blamey R. W. Density of lymphocytic infiltration of primary breast cancer does not affect short term disease free interval or survival. J. R. Coll. Surg. Edinb. 35:1990;289.
18. Kaymakcalan Z., Spitalny G. In vitro expression of secondary anti-tumor immunity by in vivo tumor-sensitized T cells inhibition by tumor induced suppersion T cells. Cancer Immunol. Immunother. 25:1987;69.
19. Kuppner M. C., Hamou M. F. Inhibition of lymphocyte function by glioblastoma derived transforming growth factor beta 2. J. Neurosurg. 143:1989;1210.
20. Miescher S., Whiteside T. Functional properties of tumor infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol. 136:1986;1899.
21. Rubbert A., Manger B., Lang N., Kalden J. R., Platzer E. Functional characterization of tumor infiltrating lymphocytes, lymph node lymphocytes and peripheral blood lymphocytes from patients with breast cancer. Int. J. Cancer. 49:1991;25.
22. Lorenzen J., Lewis C. E., McCracken D., Horak E., Greenall M., McGee J. O'D. Human tumor associated NK cells secrete increased amounts of interferon gamma and interleukin-4. Br. J Cancer. 64:1991;457.
23. Camp B. J., Dyhrman S. T., Memoli V. A., Mott L. A., Barth R. J. Jr. In situ cytokine production by breast cancer tumor infiltrating lymphocytes. Ann. Surg. Oncol. 3:1996;176.
24. Jung T., Schauer U., Heusser C., Neumann C., Rieger C. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods. 159:1993;197.
25. Asher A. L., Mule J. J. Murine tumor cells transduced with the gene for tumor necrosis factor-α evidenced for paracrine immune effects of tumor necrosis factor against tumors. J. Immunol. 146:1991;3227.
26. Gansbacher B., Bannerji R. Retroviral vector mediated γ interferon gene transfer into tunor cells generates potent and long lasting antitumor immunity. Cancer Res. 50:1990;7820.
27. Fearon E. R., Pardoll D. M. Interleukin 2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell. 60:1990;397.
28. Dranoff G., Jaffel E. Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90:1990;3539.
29. Schwartzentruber D. J., Solomon D., Rosenberg S. A., Topalian S. L. Characterization of lymphocytes infiltrating human breast cancer: Specific immune reactivity detected by measuring cytokine secretion. J. Immunother. 12:1992;1.
30. Horny H. P., Horst H. A. Lymphoreticular infiltrates in invasive ductal breast cancer. Virchows Arch. (Pathol. Anat.). 409:1986;275.
31. Whitford P., Mallon E. A., George W. D., Campbell A. M. Flow cytometric analysis of tumor infiltrating lymphocytes in breast cancer. Br. J. Cancer. 62:1990;971.